Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$230.71 - $256.74 $2.05 Million - $2.28 Million
-8,895 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$219.27 - $242.57 $122,791 - $135,839
-560 Reduced 5.92%
8,895 $2.15 Million
Q4 2021

Jan 19, 2022

SELL
$198.88 - $227.6 $1.34 Million - $1.54 Million
-6,757 Reduced 41.68%
9,455 $2.13 Million
Q3 2021

Oct 05, 2021

BUY
$212.27 - $248.7 $7,641 - $8,953
36 Added 0.22%
16,212 $3.45 Million
Q2 2021

Jul 12, 2021

SELL
$233.58 - $259.14 $846,026 - $938,605
-3,622 Reduced 18.29%
16,176 $3.94 Million
Q1 2021

Apr 22, 2021

SELL
$221.91 - $258.6 $408,758 - $476,341
-1,842 Reduced 8.51%
19,798 $4.93 Million
Q4 2020

Jan 25, 2021

BUY
$216.38 - $257.67 $293,411 - $349,400
1,356 Added 6.69%
21,640 $4.98 Million
Q3 2020

Oct 16, 2020

BUY
$234.65 - $260.95 $1.26 Million - $1.4 Million
5,381 Added 36.11%
20,284 $5.16 Million
Q2 2020

Jul 08, 2020

SELL
$197.81 - $242.74 $63,497 - $77,919
-321 Reduced 2.11%
14,903 $3.52 Million
Q1 2020

Apr 07, 2020

BUY
$182.24 - $241.7 $958,946 - $1.27 Million
5,262 Added 52.82%
15,224 $3.09 Million
Q4 2019

Jan 07, 2020

SELL
$189.21 - $243.2 $71,521 - $91,929
-378 Reduced 3.66%
9,962 $2.4 Million
Q3 2019

Nov 06, 2019

SELL
$174.11 - $208.62 $46,661 - $55,910
-268 Reduced 2.53%
10,340 $2 Million
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $29,839 - $34,978
-179 Reduced 1.66%
10,608 $1.96 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $4,160 - $4,689
-23 Reduced 0.21%
10,787 $2.05 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $164,841 - $192,423
-924 Reduced 7.87%
10,810 $2.1 Million
Q3 2018

Nov 07, 2018

SELL
$185.29 - $208.89 $389,850 - $439,504
-2,104 Reduced 15.2%
11,734 $2.43 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $531,526 - $597,018
-3,201 Reduced 18.79%
13,838 $2.55 Million
Q1 2018

May 10, 2018

SELL
$169.43 - $198.0 $187,897 - $219,582
-1,109 Reduced 6.11%
17,039 $2.91 Million
Q4 2017

Feb 07, 2018

SELL
$168.79 - $188.59 $22,786 - $25,459
-135 Reduced 0.74%
18,148 $3.46 Million
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $3.06 Million - $3.49 Million
18,283
18,283 $3.75 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ibm Retirement Fund Portfolio

Follow Ibm Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.